Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio Revenues Up 10 Percent, Profit Slips

NEW YORK (GenomeWeb News) - Harvard Bioscience yesterday said first-quarter revenue rose 10 percent as R&D spending increased 12 percent, and net income slipped 8 percent.
 
Total receipts for the three months ended March 31, 2007, increased to $19.1 million from $17.4 million year over year.
 
Harvard Bio said new sales stemming from the acquisition of Anthos' washer and microplate reader assets last June contributed 8 percent of revenue growth.
 
Fluctuations in foreign exchange rates contributed an additional 5 percent of revenue growth, but this was offset by a 3 percent decrease in organic revenue.  
 
R&D spending increased to $844,000 from $751,000 in the year-ago period. 
 
Harvard Bio reported net income of $496,000 in the quarter compared to $540,000 in the same period last year.
 
The company said it had around $8.6 million in cash and equivalents as of March 31.
 
Looking forward, Harvard Bioscience projected second-quarter revenue to be between $19.5 million and $20.5 million, and reaffirmed its expectation for revenue between $80 million and $83.0 million for full-year 2007.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.